🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Anlotinib hydrochloride is a multi-targeted receptor tyrosine kinase inhibi...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2019-10-31
Trial ID
NCT04073537
Treatments Being Tested
A randomized, double-blind, controlled, multicenter phase III study of TQB2...
Status
Unknown
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-01
Trial ID
NCT04234607
Treatments Being Tested
Evaluate the efficacy and safety of Anlotinib following concurrent chemorad...
Status
Completed
Location
China-Japan Friendship Hospital
Start Date
2019-04-12
Trial ID
NCT03743129
Treatments Being Tested
This study is a randomized, double-blind, double-dummy,placebo parallel con...
Status
Unknown
Location
Anhui Chest Hospital
Start Date
2020-05-27
Trial ID
NCT04325763
Treatments Being Tested